0,967  0,002  TNF expression inhibitor
0,923  0,003  Chemoprotective
0,918  0,003  Antihypercholesterolemic
0,914  0,005  Antiinflammatory
0,914  0,005  Apoptosis agonist
0,909  0,003  Caspase 9 stimulant
0,900  0,002  Cholesterol antagonist
0,872  0,008  Transcription factor NF kappa B inhibitor
0,866  0,004  Chemopreventive
0,834  0,002  Antiinfertility, female
0,808  0,004  Hepatic disorders treatment
0,773  0,004  NOS2 expression inhibitor
0,778  0,010  Antineoplastic (lung cancer)
0,772  0,005  Lipoprotein disorders treatment
0,767  0,003  UGT1A4 substrate
0,751  0,001  Cholesterol synthesis inhibitor
0,749  0,005  Bone diseases treatment
0,742  0,010  Antidiabetic
0,742  0,010  Cyclophilin D inhibitor
0,737  0,005  Nitric oxide antagonist
0,735  0,005  NOS3 expression inhibitor
0,732  0,006  CYP2C19 substrate
0,729  0,005  Caspase 3 stimulant
0,722  0,002  Anticataract
0,718  0,004  Apoptosis antagonist
0,717  0,005  Antiosteoporotic
0,722  0,011  Antileukemic
0,723  0,017  Antineoplastic (breast cancer)
0,697  0,012  Carcinogenic
0,687  0,007  Proliferative diseases treatment
0,682  0,010  Antineoplastic (ovarian cancer)
0,670  0,008  Antineoplastic (melanoma)
0,664  0,005  Hypolipemic
0,657  0,004  Hepatoprotectant
0,655  0,007  AR expression inhibitor
0,650  0,004  Hair growth stimulant
0,644  0,009  Cytotoxic
0,639  0,007  Antipruritic, allergic
0,638  0,014  Prostate cancer treatment
0,623  0,006  UGT1A1 substrate
0,618  0,007  Metabolic disease treatment
0,591  0,004  UGT2B4 substrate
0,592  0,009  Antineoplastic (multiple myeloma)
0,590  0,012  Antineoplastic (pancreatic cancer)
0,574  0,003  UGT2B7 substrate
0,580  0,017  Atherosclerosis treatment
0,572  0,013  Antioxidant
0,561  0,007  Antineoplastic (endocrine cancer)
0,565  0,013  Antipsoriatic
0,563  0,011  Antineoplastic (glioma)
0,567  0,021  Respiratory analeptic
0,553  0,013  Antineoplastic (brain cancer)
0,549  0,012  Antiprotozoal (Leishmania)
0,549  0,014  Antifungal
0,549  0,021  Immunosuppressant
0,557  0,033  CYP3A4 substrate
0,527  0,003  Sodium/bile acid cotransporter inhibitor
0,552  0,028  Antibacterial
0,526  0,005  Antiviral (Herpes)
0,524  0,004  DNA polymerase I inhibitor
0,547  0,028  Antiobesity
0,540  0,024  Immunostimulant
0,520  0,004  Antifungal enhancer
0,526  0,014  Antidiabetic (type 2)
0,520  0,009  ICAM1 expression inhibitor
0,516  0,005  Interferon gamma antagonist
0,511  0,001  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,536  0,027  Embryotoxic
0,508  0,003  UGT2B9 substrate
0,509  0,005  Contraceptive
0,532  0,029  Teratogen
0,508  0,009  Antineoplastic (liver cancer)
0,500  0,005  Abortion inducer
0,497  0,002  Lanosterol 14 alpha demethylase inhibitor
0,519  0,033  Antineoplastic (colorectal cancer)
0,483  0,004  Protein-tyrosine phosphatase 1B inhibitor
0,492  0,015  Antineoplastic (glioblastoma multiforme)
0,486  0,013  UDP-glucuronosyltransferase substrate
0,484  0,013  Vascular (periferal) disease treatment
0,485  0,013  Renal disease treatment
0,503  0,033  Antineoplastic (colon cancer)
0,480  0,012  Antihypoxic
0,495  0,030  Antithrombotic
0,481  0,017  Hypoglycemic
0,474  0,011  Wound healing agent
0,463  0,004  Antipruritic, non-allergic
0,464  0,007  Antiacne
0,464  0,012  Antihelmintic
0,476  0,025  Antineoplastic (cervical cancer)
0,466  0,017  Antineoplastic (lymphoma)
0,455  0,008  Phospholipase C inhibitor
0,456  0,009  Prostatic (benign) hyperplasia treatment
0,449  0,002  Bile acid receptor antagonist
0,450  0,003  Contraceptive female
0,451  0,006  Protein-tyrosine phosphatase inhibitor
0,449  0,004  AMP-activated protein kinase stimulant
0,457  0,014  Antineoplastic (renal cancer)
0,444  0,006  Lipocortins synthesis antagonist
0,443  0,008  Prostate disorders treatment
0,451  0,020  Hypoxia-inducible factor 1 alpha inhibitor
0,483  0,055  Alzheimer's disease treatment
0,441  0,016  Angiogenesis stimulant
0,442  0,018  UGT1A6 substrate
0,426  0,005  Antiviral (Influenza A)
0,439  0,020  Antiparasitic
0,419  0,009  Antiviral (Influenza)
0,416  0,007  Protein kinase stimulant
0,418  0,017  Antiulcerative
0,414  0,020  Antihypertriglyceridemic
0,424  0,033  Analeptic
0,415  0,032  UGT1A9 substrate
0,413  0,030  Sensitization
0,432  0,056  Antiprotozoal
0,378  0,006  Gastrin inhibitor
0,371  0,004  Inducible nitric-oxide synthase inhibitor
0,378  0,013  UGT1A3 substrate
0,365  0,004  Farnesoid X receptor antagonist
0,372  0,014  Melanin inhibitor
0,362  0,004  LDLR expression enhancer
0,359  0,015  Skin whitener
0,360  0,020  P-glycoprotein inhibitor
0,350  0,010  Diabetic nephropathy treatment
0,342  0,007  UGT2B1 substrate
0,351  0,019  Platelet adhesion inhibitor
0,323  0,005  Choleretic
0,330  0,015  Lipid peroxidase inhibitor
0,336  0,024  Antiviral (HIV)
0,360  0,049  Cardioprotectant
0,335  0,030  Antineoplastic enhancer
0,320  0,016  Amylase inhibitor
0,313  0,015  Liver fibrosis treatment
0,300  0,002  Arachidonic acid antagonist
0,300  0,003  5-Alpha-reductase inhibitor
0,337  0,044  Antipyretic
0,305  0,013  Phospholipase A2 inhibitor
0,298  0,009  Autism spectrum disorders treatment
0,302  0,017  Neurotrophic factor enhancer
0,325  0,044  Cardiovascular analeptic
0,304  0,024  Male reproductive disfunction treatment
0,286  0,006  UGT2B10 substrate
0,282  0,004  CDC25A inhibitor
0,323  0,044  Amyotrophic lateral sclerosis treatment
0,323  0,046  Free radical scavenger
0,289  0,014  Antiviral (Hepatitis B)
0,293  0,017  Insulin sensitizer
0,283  0,007  Alcohol dehydrogenase substrate
0,289  0,014  Antidiarrheal
0,304  0,042  Antineoplastic (lymphocytic leukemia)
0,308  0,049  Antidiabetic symptomatic
0,292  0,033  RNA-directed DNA polymerase inhibitor
0,320  0,061  Interleukin 2 agonist
0,279  0,021  UGT2B15 substrate
0,272  0,016  Insulin secretagoues
0,259  0,009  Androgen antagonist
0,274  0,025  Anesthetic
0,330  0,082  Antiprotozoal (Plasmodium)
0,274  0,027  Diuretic
0,247  0,005  Pregnane X receptor agonist
0,305  0,064  Antituberculosic
0,298  0,058  Antineoplastic (non-small cell lung cancer)
0,246  0,011  Retinoprotector
0,256  0,030  Antiviral (Hepatitis)
0,237  0,012  Microtubule formation inhibitor
0,318  0,096  CYP2C9 substrate
0,298  0,078  Antimycobacterial
0,239  0,025  Interleukin 6 antagonist
0,216  0,004  Liver X receptor alpha agonist
0,220  0,008  Transcription factor NF kappa B stimulant
0,214  0,003  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,227  0,022  Antihyperlipoproteinemic
0,222  0,018  Antineoplastic antibiotic
0,212  0,008  ABCA1 expression enhancer
0,206  0,002  Farnesoid X receptor agonist
0,202  0,002  Na+ K+ transporting ATPase inhibitor
0,234  0,034  Antineoplastic (squamous cell carcinoma)
0,249  0,051  Anesthetic general
0,312  0,116  CYP2C19 inhibitor
0,204  0,009  Actinic keratosis treatment
0,208  0,016  Liver cirrhosis treatment
0,195  0,004  Glycine receptor agonist
0,209  0,019  Antihemorrhagic
0,185  0,005  CDC25B inhibitor
0,185  0,006  UGT2B11 substrate
0,210  0,031  Antidiabetic (type 1)
0,211  0,036  Acute respiratory distress syndrome (ARDS) treatment
0,182  0,007  Anabolic
0,227  0,053  Non-steroidal antiinflammatory agent
0,178  0,004  Glycine receptor antagonist
0,177  0,004  Anticholelithogenic
0,173  0,005  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,176  0,008  Paget's disease treatment
0,246  0,083  DNA damaging
0,184  0,026  Cyclooxygenase 3 inhibitor
0,237  0,081  Tumour necrosis factor alpha release inhibitor
0,232  0,078  Antiglaucomic
0,179  0,026  Adenylate cyclase stimulant
0,194  0,044  Antineoplastic (bone cancer)
0,233  0,084  Antineoplastic (sarcoma)
0,150  0,005  Hypercalcemia treatment
0,269  0,124  Inflammatory Bowel disease treatment
0,184  0,040  Bone formation stimulant
0,150  0,007  Hyperparathyroidism treatment
0,161  0,019  Nitric-oxide synthase inhibitor
0,220  0,083  Cytostatic
0,144  0,008  Androgen agonist
0,212  0,078  Antiparkinsonian, rigidity relieving
0,184  0,050  Antineoplastic (carcinoma)
0,159  0,025  HDL-cholesterol increasing
0,145  0,013  HIV-1 integrase (Strand Transfer) inhibitor
0,154  0,024  Dementia treatment
0,156  0,029  Papain-like protease (SARS coronavirus) inhibitor
0,149  0,023  Vascular dementia treatment
0,140  0,014  Ornithine decarboxylase inhibitor
0,125  0,003  Cholesterol absorption inhibitor
0,156  0,033  Vanilloid 1 agonist
0,156  0,037  Growth stimulant
0,147  0,029  Sulfotransferase substrate
0,257  0,139  Calcium channel activator
0,225  0,107  Radioprotector
0,176  0,059  Antiviral (Hepatitis C)
0,139  0,022  Antiviral (Coronavirus)
0,139  0,022  Antiviral (SARS coronavirus)
0,213  0,098  Myocardial infarction treatment
0,133  0,020  Antiviral (Rhinovirus)
0,146  0,034  TRPA1 agonist
0,236  0,124  CTGF expression inhibitor
0,208  0,097  Antihypotensive
0,118  0,009  Acetyl-CoA transferase inhibitor
0,111  0,005  Heme oxygenase stimulant
0,174  0,068  Toxic, respiratory center
0,143  0,038  Expectorant
0,185  0,081  CYP2B6 inhibitor
0,148  0,048  Monophenol monooxygenase inhibitor
0,202  0,103  Vasodilator
0,168  0,069  Antihelmintic (Nematodes)
0,153  0,054  Psychosexual dysfunction treatment
0,114  0,015  Postmenopausal disorders treatment
0,215  0,118  Transcription factor STAT inhibitor
0,101  0,005  Lipocortins synthesis agonist
0,100  0,007  Liver X receptor agonist
0,227  0,135  Immunomodulator
0,097  0,006  RNA-directed RNA polymerase stimulant
0,110  0,020  Aromatase inhibitor
0,093  0,003  Vitamin D receptor antagonist
0,178  0,090  Growth factor agonist
0,128  0,041  Estrogen antagonist
0,155  0,067  NOS3 expression enhancer
0,209  0,122  Transcription factor STAT3 inhibitor
0,109  0,023  Lipase inhibitor
0,106  0,024  Estrogen receptor alpha antagonist
0,083  0,004  Cholesterol ester transfer protein antagonist
0,176  0,098  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,082  0,004  Parathyroid hormone antagonist
0,085  0,009  Acetyl-CoA transferase 2 inhibitor
0,080  0,004  HMG CoA reductase inhibitor
0,120  0,044  Antineoplastic, alkylator
0,102  0,026  Prostaglandin-E synthase inhibitor
0,143  0,070  Antifungal (Cryptococcus)
0,207  0,136  CYP2D6 substrate
0,083  0,012  Postcoital contraceptive
0,096  0,027  SULT1A2 substrate
0,074  0,006  5-Alpha-reductase 2 inhibitor
0,166  0,098  Sepsis treatment
0,109  0,042  Antineoplastic alkaloid
0,070  0,006  5-Alpha-reductase 1 inhibitor
0,179  0,116  VCAM1 expression inhibitor
0,134  0,075  Neurotrophic factor
0,103  0,045  SULT1E1 substrate
0,066  0,009  Microtubule stabilization
0,080  0,023  Estrogen agonist
0,094  0,037  Antibiotic
0,065  0,009  Glucocorticoid antagonist
0,116  0,060  SULT1A1 substrate
0,079  0,024  Antimycoplasmal
0,065  0,010  Geranyltranstransferase inhibitor
0,110  0,056  Toll-Like receptor 4 antagonist
0,067  0,015  Aldosterone antagonist
0,057  0,006  Tubulin agonist
0,114  0,063  Skin irritative effect
0,093  0,042  3C-Like protease (SARS coronavirus) inhibitor
0,104  0,056  Estrogen receptor beta antagonist
0,071  0,024  Botulinum neurotoxin type A inhibitor
0,116  0,071  Beta amyloid protein antagonist
0,091  0,046  Vanilloid agonist
0,076  0,031  SULT2A1 substrate
0,183  0,143  Huntington's disease treatment
0,208  0,167  Vasodilator, peripheral
0,045  0,006  CYP24 inhibitor
0,042  0,004  Hedgehog signaling activator
0,063  0,025  Pregnane X receptor antagonist
0,069  0,034  Nitric oxide donor
0,130  0,099  Thrombolytic
0,109  0,079  Alkylator
0,036  0,005  1,3-Beta-glucan synthase inhibitor
0,138  0,109  Antipruritic
0,033  0,003  Vitamin D receptor agonist
0,068  0,039  Neuraminidase (influenza) inhibitor
0,048  0,019  Acetyl-CoA transferase 1 inhibitor
0,044  0,016  Glucose-6-phosphate dehydrogenase inhibitor
0,129  0,101  Eye irritation, high
0,106  0,079  Proteasome inhibitor
0,077  0,050  Antitreponemal
0,207  0,181  GST M1-1 substrate
0,172  0,149  5 Hydroxytryptamine release stimulant
0,076  0,055  Keratolytic
0,063  0,042  Prostaglandin F2 alpha antagonist
0,028  0,008  Corticosteroid-like
0,122  0,104  Mutagenic
0,023  0,005  Telomerase stimulant
0,028  0,011  Estrone sulfatase inhibitor
0,093  0,077  Hedgehog signaling inhibitor
0,122  0,106  Genotoxic
0,048  0,032  Cholesterol esterase inhibitor
0,024  0,008  Apical sodium codependent bile acid transporter inhibitor
0,029  0,015  Retinoid X gamma receptor antagonist
0,035  0,020  Squalene synthetase inhibitor
0,084  0,071  Contraceptive male
0,073  0,061  Narcotic antagonist
0,088  0,077  Interleukin 12 antagonist
0,078  0,068  Ca(v)3.1 blocker
0,013  0,008  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,030  0,025  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,129  0,125  Ca2+-transporting ATPase inhibitor
0,030  0,026  Estrogen receptor alpha agonist
0,081  0,079  Prolactin inhibitor
0,047  0,044  Protein 50S ribosomal subunit inhibitor
0,005  0,002  Vitamin D-like
0,065  0,065  Phospholipase D inhibitor

